Read + Share
Evans D, Kenyon K, Ousler G, Watson M, et al. Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of
Patients with Dry Eye Disease. J Ocul Pharmacol Ther 2023;39:600-610.
PMID: 37677000
|
 |
|
Evans D, Kenyon K, Ousler G, Watson M, et al. Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of
Patients with Dry Eye Disease. J Ocul Pharmacol Ther 2023;39:600-610.
PMID: 37677000
|
|
|
|